Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Medtronic Cardiovascular
With
NAMSA
DISSECT-N is a prospective, observational, global, multi-center, post-market registry designed to assess real-world safety and effectiveness of Valiant Navion Thoracic Stent Graft System in the treatment of thoracic aortic dissections in real world practice.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subject is ≥18 years old
Subject was treated in the last 7 days, or is intended to be treated, with the Valiant Navion Thoracic Stent Graft System for a dissection in the thoracic aorta
Subject is willing to comply with standard of care clinical follow-up
Subject or legal representative or consultee, as applicable has consented for study participation and signed the approved Informed Consent
You may not be if
Subject is participating in an investigational drug or device study which may bias or interfere with the endpoints and follow-up of this study.
Subject is pregnant (not an exclusion if allowed per local regulatory requirements, pregnancy test to be performed where required)
Subject has an active COVID-19 infection or relevant history of COVID-19. Relevant history of COVID-19 is defined as availability of a positive COVID-19 test with sequela or hospitalization for treatment of COVID-19. Subjects with a positive COVID-19 test who were asymptomatic or had mild symptoms should be excluded only if the positive test was less than 3 months prior to enrollment.
